CCR9/CXCR5 CO-EXPRESSING CD4 T CELLS ARE INCREASED IN PRIMARY SJOGREN'S SYNDROME AND ENRICHED IN PD-1/ICOS EXPRESSING EFFECTOR T CELLS

被引：0
|
作者：
Hinrichs, A. [1 ]
Leavis, H. [1 ]
Kruize, A. [1 ]
Lafeber, F. [1 ]
Van Roon, J. [1 ]
机构：
[1] UMC Utrecht, Dept Rheumatol Clin Immunol, Ctr Translat Immunol, Utrecht, Netherlands
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2022年 / 40卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [41] Increased levels of CCR7(lo) PD-1(hi) CXCR5+ CD4+ T cells, and associated factors Bcl-6, CXCR5, IL-21 and IL-6 contribute to repeated implantation failure
    Gong, Qiaoqiao
    Zhu, Yuejie
    Pang, Nannan
    Ai, Haiquan
    Gong, Xiaoyun
    La, Xiaolin
    Ding, Jianbing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (06) : 5931 - 5941
  • [42] FoxP3+CXCR5+CD4+ T cell frequencies are increased in peripheral blood of patients with primary Sjogren's syndrome
    Ivanchenko, M.
    Aqrawi, L. A.
    Bjork, A.
    Wahren-Herlenius, M.
    Chemin, K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (03): : 305 - 309
  • [43] Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function
    Gorman, Jacob V.
    Colgan, John D.
    IMMUNOLOGY, 2018, 154 (03) : 418 - 433
  • [44] Endogenous tumor-reactive CD8+ T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth
    Liu, Xin
    Gibbons, Rachel M.
    Harrington, Susan M.
    Krco, Christopher J.
    Markovic, Svetomir N.
    Kwon, Eugene D.
    Dong, Haidong
    ONCOIMMUNOLOGY, 2013, 2 (06)
  • [45] Enhanced co-expression of TIGIT and PD-1 on γδ T cells correlates with clinical features and laboratory parameters in patients with primary Sjogren's syndrome
    Song, Saizhe
    Yang, Yanhong
    Ren, Tian
    Shen, Yu
    Ding, Sisi
    Chang, Xin
    Liu, Cuiping
    CLINICAL RHEUMATOLOGY, 2025, 44 (03) : 1245 - 1257
  • [46] The role of Th9 CD4+ T cells and IL-9 during primary Sjogren's syndrome
    Yang, Jie
    Su, Juan
    Chai, Kexia
    Liu, Huihui
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
  • [47] Increased levels of CD4+ and CD8+ T cells expressing CCR1 in patients developing allograft dysfunction; a cohort study
    Foroughi, Farshad
    Amirzargar, Aliakbar
    Ahmadpoor, Pedram
    Noorbakhsh, Farshid
    Nafar, Mohsen
    Yekaninejad, Mir Saeed
    Hosseinzadeh, Morteza
    Shabaz, Sanaz Keshavarz
    Barabadi, Mehri
    Ghorbanpour, Mina
    Sarrafnejad, Abdolfattah
    TRANSPLANT IMMUNOLOGY, 2016, 38 : 67 - 74
  • [48] Increased TIGIT+PD-1+CXCR5-CD4+T cells are associated with disease activity in rheumatoid arthritis
    Luo, Qing
    Fu, Peng
    Guo, Yongqin
    Fu, Biqi
    Guo, Yang
    Huang, Qingshui
    Huang, Zikun
    Li, Junming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (04)
  • [49] ROSNILIMAB, A NOVEL PD-1 AGONIST MONOCLONAL ANTIBODY, REDUCES T CELL PROLIFERATION, INFLAMMATORY CYTOKINE SECRETION, AND PD-1 [HIGH] EXPRESSING CD4 AND CD8 T CELLS: RESULTS FROM A PHASE 1 HEALTHY VOLUNTEER CLINICAL TRIAL
    Luu, Kenneth
    Dahl, Martin E.
    Hare, Eric
    Sibley, Cailin
    Lizzul, Paul
    Randazzo, Bruce
    GASTROENTEROLOGY, 2024, 166 (05) : S811 - S812
  • [50] Circulating Precursor CCR7loPD-1hiCXCR5+CD4+ T Cells Indicate Disease Activity in Sjogren's Syndrome
    He, J.
    Chen, Y. P.
    Wei, Y. B.
    Sun, X. L.
    Hou, Z. H.
    Zhang, X.
    Jin, Y. B.
    Hu, X.
    Yu, D.
    Li, Z. G.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 81 (05) : 384 - 384
12345